The industry's potential excipient folly: what companies should know about "everything" that goes into the manufacture of a dietary supplement or ... An article from: Nutraceuticals World
Book Details
Author(s)Todd Harrison, Debra Goldstein
PublisherRodman Publications, Inc.
ISBN / ASINB0008DP8D8
ISBN-13978B0008DP8D0
AvailabilityAvailable for download now
Sales Rank9,949,058
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from Nutraceuticals World, published by Rodman Publications, Inc. on June 1, 2003. The length of the article is 1438 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: The industry's potential excipient folly: what companies should know about "everything" that goes into the manufacture of a dietary supplement or ingredient. (Capitol Comments).
Author: Todd Harrison
Publication:Nutraceuticals World (Magazine/Journal)
Date: June 1, 2003
Publisher: Rodman Publications, Inc.
Volume: 6 Issue: 6 Page: 26(2)
Distributed by Thomson Gale
Citation Details
Title: The industry's potential excipient folly: what companies should know about "everything" that goes into the manufacture of a dietary supplement or ingredient. (Capitol Comments).
Author: Todd Harrison
Publication:Nutraceuticals World (Magazine/Journal)
Date: June 1, 2003
Publisher: Rodman Publications, Inc.
Volume: 6 Issue: 6 Page: 26(2)
Distributed by Thomson Gale
